This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
I analyzed those general results with health/care implications here in Health Populi. In this study, the healthcare industry is comprised of five segments: hospitals and clinics; pharma; biotech (separate from pharma); consumer health (e.g., over-the-counter medicines); and, health insurance.
These concerns fall into the buckets of health insurance coverage, or lack thereof; insurance denials; affordability for the breakthrough therapies; and, potential risks of future denials for insurance based on the patient’s personalized genomic or other healthdata. They are certainly inter-related.
“Google’s ‘Project Nightingale’ Gathers Personal HealthData on Millions of Americans,” the Wall Street Journal reported in today’s paper and on the WSJ.com website. health care. health care for privacy legislation and work flows that prioritize patient rights over their data.
This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies. Wearable devices: This includes companies that develop and sell wearable devices that track healthdata, such as fitness trackers and smartwatches.
and the Chinese Communist Party (CCP) and House Select Subcommittee on the Coronavirus Pandemic, the BIOSECURE Act is intended to control the biotech supply chain and secure citizens’ genetic data. Yet it targets specific companies without the broader context of looking at how companies collect or maintain personal genetic data.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content